Screening of Male Patients with Autism Spectrum Disorder for Creatine Transporter Deficiency

Abstract

Creatine deficiency syndromes (CDS) are newly identified genetic disorders that result in neurological impairment of cognition and communication. The purpose of our study was to screen 100 male subjects with autism spectrum disorder for mutations in the SLC6A8 gene in order to determine the frequency of this genetic disorder in this population. One hundred males ages 3-18 years diagnosed with autism spectrum disorder based on DSM-IV criteria were recruited. DNA sequence analysis was performed on all subjects for creatine transporter gene (SLC6A8) defects. One subject had a novel unclassified variant in the SLC6A8 gene exon 13: c.1890G>C. Given that autistic features are found in a number of patients with CDS, SLC6A8 deficiency as well as the treatable forms of CDS should be included in the differential diagnosis of patients with autism spectrum disorder.

Key words

creatine - autistic disorder - chromosome aberrations - inborn errors of metabolism

References

• 1 Cecil KM, Salomons GS, Ball WS, Wong B, Chuck G, Verhoeven NM. et al . Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?.  Ann Neurol. 2001;  49 401-404
• 2 Collins JS, Schwartz CE. Detecting polymorphisms and mutations in candidate genes.  Am J Hum Genet. 2002;  71 1251-1252
• 3 Grauw TJ, Salomons GS, Cecil KM, Chuck G, Newmeyer A, Schapiro M. et al . Congenital creatine transporter deficiency.  Neuropediatrics. 2002;  33 232-238
• 4 Grauw TJ, Cecil KM, Byars AW, Salomons GS, Ball WS, Jakobs C. The clinical syndrome of creatine transporter deficiency.  Mol Cell Biochem. 2003;  244 45-48
• 5 Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC. et al . The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.  J Autism Dev Disord. 2000;  30 205-223
• 6 Newmeyer A, Cecil KM, Schapiro M, Clark JF, Grauw TJ. Incidence of brain creatine transporter deficiency in males with develop-mental delay referred for brain MRI.  J Dev Behav Pediatr. 2005;  26 276-282
• 7 Rice C. Prevalence of autism spectrum disorders-autism and developmental disabilities monitoring network, six sites, United States 2000.  MMWR Morb Mortal Wkly Rep. 2007;  56 ((SS01)) 1-11
• 8 Rosenberg EH, Almeida LS, Kleefstra T, Grauw RS, Yntema HG, Bahi N. et al . High prevalence of SLC6A8 deficiency in mental retardation.  Am J Hum Genet. 2004;  75 97-105
• 9 Rosenburg EH, Martinez Munoz C, Betsalel OT, Dooren SJ van, Fernandez M, Jakobs C, Grauw TJ, Kleefstra T, Schwartz CE, Salomons GS. Functional characterization of missense variants in the creatine transporter gene (SLC6A8): improved diagnostic application.  Hum Mutat. 2007;  9 890-896
• 10 Salomons G, Dooren SJM van, Verhoeven NM, Cecil KM, Ball WS, Degrauw TJ. et al . X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.  Am J Hum Genet. 2001;  68 1497-1500
• 11 Salomons GS, Dooren SJ van, Verhoeven NM, Marsden D, Schwartz C, Cecil KM. et al . X-linked creatine transporter defect: an overview.  J Inherit Metab Dis. 2003;  26 309-318
• 12 Salomons GS, Bok LA, Struys EA, Pope LL, Darmin PS, Mills PB, Clayton PT, Willemsen MA, Jakobs C. An intriguing “silent” mutation and a founder effect in antiquitin (ALDH7A1).  Ann Neurol. 2007;  62 414-418
• 13 Schulze A. Creatine deficiency syndromes.  Mol Cell Biochem. 2003;  244 143-150
• 14 Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stockler-Opsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes.  Acta Biochim Polonica. 2004;  51 875-882

Correspondence